Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis
about
The Vpr protein from HIV-1: distinct roles along the viral life cycleHIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasomeHuman immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathwayThe mitochondriotoxic domain of Vpr determines HIV-1 virulenceAnalysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiaeVisualizing Vpr-induced G2 arrest and apoptosisHuman immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanismRoles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactionsEvolutionary modeling of rate shifts reveals specificity determinants in HIV-1 subtypesNuclear exportin receptor CAS regulates the NPI-1-mediated nuclear import of HIV-1 VprViremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and functionMatrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes.HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANTCD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation.Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia.The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90Characterization of the molecular determinants of primary HIV-1 Vpr proteins: impact of the Q65R and R77Q substitutions on Vpr functions.The identification of unique serum proteins of HIV-1 latently infected long-term non-progressor patients.Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replicationR77Q and Q3R HIV1-VPR mutations in an otherwise asymptomatic 5-year-old child with repeated ear infectionsAnalysis of human immunodeficiency virus cytopathicity by using a new method for quantitating viral dynamics in cell culture.Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progressionPP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins.Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5- and X4-Associated HIV-1 Vpr SequencesVpr-host interactions during HIV-1 viral life cycle.Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic ControllersBacterial DNA Protects Monocytic Cells against HIV-Vpr-Induced Mitochondrial Membrane Depolarization.Endothelial cells promote human immunodeficiency virus replication in nondividing memory T cells via Nef-, Vpr-, and T-cell receptor-dependent activation of NFAT.Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection.Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressorsThe relationship between antibody to R7V and progression of HIV type 1 infectionThe host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domainsModulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection.The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrestMechanisms of HIV-associated lymphocyte apoptosis: 2010The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemiasBroadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremiaCharacterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease.
P2860
Q21245211-A16D12FE-4E13-417A-A508-B657A3097DD2Q24338212-D501B736-34C7-4363-8409-7FB8F5B79D05Q24530134-2B180800-6BA8-43F5-B069-AA7B14456464Q24674929-CA78A5DC-9A46-49D5-8FF5-A3491ED80C37Q24804945-9415BA78-0FAF-476E-9432-0AC8A58EE012Q27329545-175C86F6-CAFA-493E-B74C-3E040DABE97CQ28245301-56D1C5D9-2781-4B5D-8FF3-970B643D05E7Q28286819-EAAB75F0-F6D4-47CD-AE21-651DC7428269Q28473878-4886BEC7-8DD4-40E5-BEDF-E9C0180E6E14Q28478027-E880224B-7F01-420E-95FE-8BDBC258C312Q28732293-C1966028-8005-4DF9-B073-414F0DE3F9F8Q30491528-4D3F5446-7511-413D-BEB0-A8BE8E1ED15BQ33265220-4466E972-D8DE-4392-A104-C8D0D10C522DQ33305428-1E008762-5E04-46D5-ABE3-C2EC7EE2F45CQ33344436-F5BBD6ED-8CC4-4224-9FB0-B011170C81C5Q33466002-7C3649D2-D4C5-4F23-8714-0967A6BEB53DQ33511235-B5008953-8AF2-45BA-877F-EF2E1071C2B5Q33626049-DF351850-C762-4FC6-B147-7F9B9AA71114Q33631183-CA24A192-DB3E-4173-9799-BB3CD57530F6Q33635218-33760436-1A2B-4CD4-9E5C-9C042F726B8AQ33707384-9BD2BD88-89DE-4ED8-9DCA-A284D1DAD110Q33725746-C996E2D2-5E7E-4DC3-AE7C-A68C7CB00EAAQ33745009-E651F6CE-C784-4116-9338-1E116BF09E79Q33768060-37F45B4F-48AD-4C2E-AAFB-C971FA9B74E0Q33828332-27657AD5-137A-4C28-AB40-02F5CED2BC0DQ33828507-7AD01327-CC33-409C-88B5-DEBC606D74BEQ33846203-EAA51DEF-F46E-4029-ACAA-0C1562A735A7Q33930388-C136F617-9947-4C0B-882B-E284C566CC98Q33990739-8093B17F-05CE-4ADB-9419-CDBD406A4B2EQ34079006-8B78E891-0F63-420E-B8FA-AB31FE42D030Q34103197-FE79BDCE-8D2A-43E3-B6EA-2E9760F89837Q34106660-2DF0F01C-6D96-4118-85DE-887569EDC275Q34220186-46D784BB-E922-4216-92CF-59F4DF170187Q34270602-2FF0F740-C7FC-4F0C-AF48-61CBBC2F5D0CQ34480135-A8B5C698-71AC-478E-9EC9-41D723AFED69Q34545417-9B5D5F41-4B8D-4E70-A684-C2561B37794EQ34712821-28DCA50A-5348-4516-B345-A21054B0FD49Q35070255-FD0AA7B8-56FE-437C-8988-A202709B02F5Q35077039-C2C38B87-3AC5-445B-AB39-7131C13B5497Q35127401-B18AA402-E631-4E52-B9C4-FDEC9A91867A
P2860
Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Vpr R77Q is associated with lo ...... mpaired induction of apoptosis
@ast
Vpr R77Q is associated with lo ...... mpaired induction of apoptosis
@en
Vpr R77Q is associated with lo ...... mpaired induction of apoptosis
@nl
type
label
Vpr R77Q is associated with lo ...... mpaired induction of apoptosis
@ast
Vpr R77Q is associated with lo ...... mpaired induction of apoptosis
@en
Vpr R77Q is associated with lo ...... mpaired induction of apoptosis
@nl
prefLabel
Vpr R77Q is associated with lo ...... mpaired induction of apoptosis
@ast
Vpr R77Q is associated with lo ...... mpaired induction of apoptosis
@en
Vpr R77Q is associated with lo ...... mpaired induction of apoptosis
@nl
P2093
P2860
P3181
P356
P1476
Vpr R77Q is associated with lo ...... mpaired induction of apoptosis
@en
P2093
Andrew D Badley
André A Pilon
David Lynch
Eric A Cohen
Jaime Sanchez-Dardon
Joel G Weaver
John E Kim
Julian J Lum
Michael Montpetit
Nanci Hawley
P2860
P304
P3181
P356
10.1172/JCI16233
P407
P577
2003-05-01T00:00:00Z